Supplemental Data for:
Supplemental Data for: Metabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia Patients by Aishen Gong, Xiaoyan Chen, Pan Deng and Dafang Zhong Drug Metabolism and Disposition. Figure S1 1 H NMR spectrum of M0.
320 views • 16 slides